MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shweta Dhoot & PACs MANGALAM DRUGS & ORGANICS LTD. - 532637 - Closure of Trading Window
In terms of provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and Company's Code for prohibition of Insider Trading, the Trading Window for dealing in securities of the Company shall remain closed for Designated Persons (including their immediate relatives) from January 1, 2023 till the expiry of forty-eight (48) hours after the declaration of Unaudited Financial Results of the Company for the quarter / nine months ended December 31, 2022. MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 09, 2022 for Shree Rasbihari Trading and Investment Pvt Ltd MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 02, 2022 for Shree Kishoriju Trading and Investments Pvt Ltd MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 23, 2022 for Shree Kishoriju Trading & Investments Pvt Ltd MANGALAM DRUGS & ORGANICS LTD. - 532637 - Compliance Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of Related Party Transactions, for the period ended September 30, 2022. MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find enclosed herewith copies of newspaper advertisement for Un-Audited Financial Results of the Company for the period ended September 30, 2022 published in Financial Express (English daily) and Loksatta (Marathi daily). MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith copies of newspaper advertisement for Un-Audited Financial Results of the Company for the period ended September 30, 2022 published in Financial Express (English daily) and Loksatta (Marathi daily), dated November 12, 2022.
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Outcome Of Board Meeting Held On Friday, November 11, 2022
Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., November 11, 2022 transacted the following business: 1. Considered & approved the Un-Audited Financial Results for the period ended September 30th, 2022 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations;